Avalo Therapeutics, Inc. · NASDAQ:AVTX

Logos Global Management LP reported a 5.60% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Mar 26, 2026 · Filed Apr 1, 2026

Logos Global Management LP reported a 5.60% stake in Avalo Therapeutics, Inc., 1,285,000 shares, as a passive investor on Mar 26, 2026. Filed Apr 1, 2026 (Schedule 13G).

Stake
5.60%
Shares
1,285,000
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Logos Global Management LP5.60%1,285,000
Logos Global Management GP LLC5.60%1,285,000
Logos Global Master Fund LP5.60%1,285,000
Logos GP LLC5.60%1,285,000
Arsani William5.60%1,285,000

Source

View original at SEC

Related